CD1D and metabolic dysfunction-associated steatotic liver disease: CD1d-dependent NKT cells improved non-alcoholic fatty liver disease (NAFLD)-associated CKD via reducing renal inflammation, mesangial cell proliferation, and tubular cell apoptosis (Alhasson et al., 2016).